Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.8.13 extracted from

  • Le Corre, L.; Gravier-Pelletier, C.; Le Merrer, Y.
    Towards new MraY inhibitors: a serine template for uracil and 5-amino-5-deoxyribosyl scaffolding (2007), Eur. J. Org. Chem., 2007, 5386-5394.
No PubMed abstract available

Application

Application Comment Organism
drug development biological activity of uridine moiety in naturally occurring non-specific MraY inhibitors (like liposidomycins and caprazamycins), antibacterial chemotherapy against pathogenic bacteria being multiresistant to common antibiotics Bacteria

Inhibitors

Inhibitors Comment Organism Structure
N-(uracilylpentyl)-beta-D-O-(5-amino-5-deoxyribosyl)-L-serine synthesis of analogue of naturally occurring inhibitors like liposidomycins and caprazamycins in which uridine moiety is replaced by a C5 acyclic alkyl chain, and uracil, aminoribose and amino acid moieties are retained Bacteria

Organism

Organism UniProt Comment Textmining
Bacteria
-
-
-

Synonyms

Synonyms Comment Organism
MraY
-
Bacteria
MraY translocase
-
Bacteria